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Abstract: This review summarizes the microbiology, and antimicrobial management of mycotic aneurysm of the aorta 
(MAA) due to anaerobic bacteria. Anaerobic bacteria are an uncommon but important cause of MAA. Most cases of 
anaerobic MAA are caused anaerobic gram-negative bacilli  (mostly  B. fragilis group), Clostridium  spp. (mostly 
Clostridium septicum, and Propionobacterium spp. (mostly P. acnes). Clostridial infection is frequently associated with 
gastrointestinal or hematologic malignancy. A review of all the reported cases is presented. Treatment of MAA involving 
anaerobic bacteria includes the use of antimicrobial effective against these organisms.  
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INTRODUCTION 
  Infections due to anaerobic bacteria are common, and can 
be serious and life-threatening. The recent increased in the 
recovery of these organisms in all infectious sites [1] 
including bacteremia [2] has led to greater appreciation of 
the role anaerobes play in infections at all body sites, 
including mycotic aneurysm of the aorta (MAA).  
  As the main components of the normal human skin and 
mucous membranes bacterial flora, anaerobes are a common 
cause of endogenous bacterial infections. Because of their 
fastidiousness, they are difficult to isolate from infected 
sites, and are often overlooked. Their exact frequency is hard 
to ascertain because of the inconsistent utilization of 
adequate methods for their isolation and identification. The 
lack of directing adequate antimicrobial therapy against these 
organisms may lead to clinical failures, complication and 
increase mortality. Their isolation requires appropriate 
methods of collection transportation and cultivation of 
specimens. Treatment of anaerobic infection is complicated 
by their polymicrobial nature, and by the slow growth and 
growing resistance to antimicrobials of anaerobic bacteria 
[3]. 
  MAA is a life-threatening condition with significant 
morbidity and mortality. Staphylococcus and Salmonella 
spp. are the two most commonly cultured organisms in 
mycotic aneurysms. However, improved bacteriologic 
techniques have led to the detection of anaerobic bacteria 
(mostly  Bacteroides, and Clostridium spp.) in MAA [4]. 
This review describes the microbiology and antimicrobial 
management of MAA due to anaerobic bacteria. 
MICROBIOLOGY 
  The study by Brook and Frazier [4] illustrated the 
diversity of anaerobic bacteria recovered from patients with 
MAA. The study was conducted between 1987 and 1992 and  
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presented 8 cases with MAA who had aerobic and anaerobic 
cultures. Eleven organisms, 6 aerobic and facultative and 5 
anaerobic, were isolated. Aerobic organisms only were 
isolated in 4 cases, anaerobic organisms only in 3, and mixed 
aerobic and anaerobic bacteria in one. Polymicrobial 
infection was present in three. The isolated aerobic bacteria 
were Staphylococcus aureus (2 isolates), and Staphylococcus 
epidermidis, Escherichia coli, Klebsiella pneumoniae, and 
Salmonella enteritidis (one each). The recovered anaerobes 
were Peptostreptococcus spp. (2), and Bacteroides fragilis, 
Propionibacterium acnes, and Clostridium perfingens (one 
each). Organisms similar to the one recovered from the 
MAA were isolated from the blood of 4 patients. These 
include one isolate each of S. aureus, E. coli, B. fragilis, and 
C. perfringens. 
  Several case reports of MAA due to anaerobic bacteria 
(mainly  B. fragilis and Clostridium septicum)  were 
published. 
Bacteroides fragilis Infections 
  Sheehan [5] presented a patient with aortitis due to 
Bacteroides  spp. that developed MAA, which ruptured 
following translumbar aortography. Reddy et al. [6] reported 
a patient with a 7 cm saccular MAA due to B. fragilis that 
emerged in the suprarenal abdominal area. 
 Suddleson  et al. [7] presented a case of mycotic 
suprarenal MAA caused by B. fragilis. The patient was 
treated only with continuous antibiotic therapy and had a 
complete recovery. Taylor et al. [8] described a patient with 
infected abdominal aortoiliac mycotic aneurysm caused by 
Bacteroides spp. The patient was treated with appropriate 
antibiotics and a single operative procedure consisting of 
preliminary extraanatomic bypass followed by complete 
aneurysm excision and posterior drainage of the retroperi-
toneum. Jewkes and Black [9] reported a case with MAA 
caused by a Gram-negative anaerobic organism. The MAA 
was in the abdominal area and was a consequence of an 
abscess of the appendix.  
 Reddy  et al. [10] performed a 30-year retrospective 
review and identified 13 patients treated for infected 
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(31%) of the patients died within 30 days of operation, three 
of whom of aneurysmal rupture. Salmonella spp., B. fragilis, 
S. aureus and  Pseudomonas  aeruginosa  accounted for all 
deaths, ruptures, and suprarenal aneurysm infections which 
occurred in 10 (77%) of the patients. 
 Hsu  et al. [11] performed a retrospective review of all 19 
patients with MAA treated at a single center over 5 years. 
The most common pathogens were Salmonella spp. (74%) 
and Streptococcus spp. (11%). There was a single case of B. 
fragilis who did not survive.  
 Matsuyama  et al. [12] successfully-treated a patient with 
acute MAA due to B. fragilis by placing a dacron graft 
replacement between the distal arch and the proximal 
descending aorta with teflon felt reinforcement, and covering 
the graft with omental flap.  
 Tsuji  et al. [13] successfully treated a patient with a 
mycotic aneurysm caused by B. fragilis of the common iliac 
artery complicated with vertebral spondylitis. Under midline 
laparotomy, complete debridement of the infected tissues, in-
situ replacement of the common iliac artery with cryopre-
served aortic allograft, and iliac bone autotransplantation and 
omentopexy to fill the debrided cavity were performed.  
 Beland  et al. [14] described a patient suffering from 
leprosy that developed B. fragilis sepsis and MAA. 
Clostridium septicum Infections  
 Takano  et al. [15] reported a case of mycotic aneurysm 
of the infrarenal abdominal aorta infected by C. septicum and 
reviewed 18 addition cases. Of the total of 19 cases of 
aneurysm caused by C. septicum that have been reported, 
[16-33]
 at the time of the review the aneurysm was located in 
the abdominal aorta in 6, the thoracic in 4, the 
thoracoabdominal in 2, the iliac artery in 2, the popliteal 
artery in 1, and the thoracic aorta and abdominal aorta 
(double aneurysm) in 1 patient. In addition, two cases of 
aortic dissection caused by C. septicum infection have been 
reported
 [32, 33]. In these 19 cases, there were 14 with colon 
neoplasm, 11 of which were colon cancer. Ten of the 12 
patients who underwent vascular surgery survived, whereas 
all 7 who did not undergo surgery died, mostly from 
aneurysmal rupture. Thus, surgical treatment seems to be 
needed to achieve optimal results.  
  A typical finding of clostridial mycotic aneurysms in the 
CT scan is gas formation surrounding the aorta or peripheral 
arteries
  [15]. Clostridia can proliferate in tissues when 
oxidation-reduction falls or the pH is reduced, which may 
occur with arterial injury, necrotic tissue, or anoxic tissue 
with lactic acid accumulation. For this reason, clostridial 
infection is frequently associated with gastrointestinal or 
hematologic malignancy. Kornbluth et al. [34]
 reported an 
associated malignancy in 81% of patients with C. septicum 
infection, and other studies have reported similar findings 
[17, 35]. It is believed that ulcerative lesions of the gastro-
intestinal tract, especially colon carcinoma, can allow 
clostridial organisms to enter the bloodstream and seed an 
atherosclerotic focus in the aorta, resulting in the 
development of MAA [36]. The diagnosis of clostridial 
MAA requires therefore a thorough search for an occult 
malignancy.  
  Three additional cases of MAA due to C. septicum not 
included in the above review were also recently reported [37-
39]. 
 Clostridium  paraputrificum was also reported to be 
associated in a single case of AMA in a patient with a 
myeloproliferative disorder and a necrotic carcinoma of the 
colon [40].  
Propionibacterium acnes Infections 
  In addition to the patient with P. acnes MAA, described 
by Brook and Frazier [4], another patient was reported by 
Galema et al. [41]. 
  Data recently reported by Marques da Silva et al. [42] 
sheds light about the potential role of Propionibacterium 
species as well as other anaerobic bacteria in the etiology of 
aortic aneurysms.  The authors evaluated 53 samples from 
aneurysm walls that were collected from 49 patients during 
reconstructive surgery. The tissue specimens were sectioned 
and cultured under anaerobic conditions. Anaerobic 
cultivation yielded bacteria in 14 of the 53 samples (26.4%). 
All bacteria were gram-positive cocci or rods from nine 
genera and 12 species. Five cultures (35%) were mixed, 
containing two bacterial species. Mixed aerobic and 
anaerobic species were found in four samples (28.5%). 
Anaerobic bacteria were recovered from 10 of 14 positive 
cultures (71%). Among the anaerobes found were P. acnes 
(5 instances), and Propionibacterium granulosum, Actino-
myces viscosus, Actinomyces naeslundii, and  Eggerthella 
lenta (1 each). In further investigation Marques da Silva et 
al. [43] examined 10 aortic aneurysms for the presence of 
bacterial DNA using polymerase chain reaction (PCR) 
targeting the 16S ribosomal RNA (rRNA) gene, followed by 
cloning and sequencing. Sequences of P. acnes were 
identified in five samples and Prevotella melaninogenica 
were detected in one sample.  
  The authors concluded that the presence of bacteria in 
aortic aneurysms did not necessarily imply a causal 
relationship in aneurysm initiation and development, and 
some of these bacteria might have been secondary colonizers 
of a previously damaged vessel. However, their presence 
demonstrates the ability of anaerobic bacteria to reach the 
aortic aneurysms and participate in some instances in the 
mycotic process. 
ANTIMICROBIAL MANAGEMENT OF MYCOTIC 
ANEURISM DUE TO ANAEROBIC BACTERIA 
  Management of MAA is one of the most challenging 
clinical problems. Successful resolution of MAA depends on 
early diagnosis, prolonged antibiotic therapy, and timely 
surgery. Management options of MAA include antibiotic 
therapy alone or in combination with surgical or 
endovascular therapy. No data is available regarding the 
effects of medical therapy alone for aneurysm infected by 
anaerobic bacteria. Therefore this section addresses the 
antimicrobial choice of agents to be used with or without 
surgery. Surgical treatment seems to be needed to achieve 
optimal results based on the review of C. septicum MAA by 
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  The initial therapy, which is generally empirical should 
cover the most likely infecting organisms. Antimicrobial 
effective against anaerobic bacteria should be administered 
empirically whenever their presence is suspected or proven. 
The final choice of antimicrobial agents should be based on 
isolation of specific organisms, aerobes as well as anaerobes 
from the blood or infected site and antimicrobial 
susceptibility testing done. Parenteral antimicrobial therapy 
for four to six weeks is recommended for the treatment of a 
MAA [44]. A longer treatment is considered when 
parameters of inflammation such as C-reactive protein, 
erythrocyte sedimentation rate, and white cell count do not 
return to normal.  
  The susceptibility of anaerobic bacteria to antimicrobial 
agents has become less predictable and resistance to several 
antimicrobial agents by B. fragilis group and other anaerobic 
Gram-negative bacilli has increased over the past decade [3, 
45]. It is therefore important to perform susceptibility testing 
to the isolates recovered from patients with MAA.  
  The parenteral antimicrobials generally effective against 
anaerobic bacteria are clindamycin, metronidazole, chlor-
amphenicol, cefoxitin, a combination of penicillin (i.e., 
ticarcillin, ampicillin) plus a beta-lactamase inhibitor (i.e., 
clavulanate, sulbactam), tigecycline, moxifloxacin, and the 
carbapenems (i.e. imipenem, meropenem). Aminoglycosides 
or a quinolones generally is added to clindamycin, metro-
nidazole and, occasionally, cefoxitin to provide coverage for 
enteric bacteria, and to a carbapenem to cover for 
Pseudomonas [3, 45]. Penicillin is added to metronidazole to 
cover for microaerophilic streptococci, Actinomyces spp. and 
Propionibacterium spp. Penicillin is added to clindamycin to 
supplement its coverage against Peptostreptococcus spp. and 
other Gram-positive anaerobic organisms. 
  Antimicrobial agents that generally provide coverage for 
methicillin-susceptible  S. aureus as well as for anaerobic 
bacteria include cefoxitin, clindamycin, carbapenem, 
tigecycline, and combinations of penicillin (e.g., ticarcillin) 
and a beta-lactamase-resistant penicillin. A glycopeptide 
(e.g., vancomycin), daptomycin, tigecycline, linezolid, and 
quinupristin/dalfopristin should be administered in cases in 
which methicillin-resistant S. aureus is present or suspected.  
CONCLUSIONS 
  Anaerobic Gram-negative bacilli  (mostly  B. fragilis 
group),  Clostridium  spp. (mostly C. septicum), and 
Propionibacterium  spp.  (mostly P. acnes) are the 
predominant anaerobes isolated from MAA. Because 
anaerobic Gram-negative bacilli have increased their 
resistance to penicillins and other antimicrobials in recent 
years, complete identification and antimicrobial 
susceptibility testing are essential for the management of 
infections caused by anaerobic bacteria. The mainstay of 
treatment of MAA involving anaerobes includes the use of 
antibiotic therapy effective these organisms.  
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